D

Deep-Insight

Europe, Cork, Ireland, Cork

Description

Deep-Insight provides services in B2B customer experience, data analytics, CRM and employee engagement to its clients.

Investor Profile

Deep-Insight has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Deep-Insight frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Arc Ventures
North America, New York, United States, New York
Co-Investments: 1
Deep Insight
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Insight Partners
North America, New York, United States, New York
Co-Investments: 1
Delos Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
CRISPR Therapeutics
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
JP Morgan
North America, New York, United States, New York
Co-Investments: 1
Innovation Endeavors
North America, California, United States, Palo Alto
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Deep-Insight?

Exsilio Therapeutics

Boston, Massachusetts, United States

Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

Biotechnology
Series AJun 25, 2024
Amount Raised: $82,000,000